Literature DB >> 21354518

The relationship between renal functions and thrombolysis in myocardial infarction frame count in patients with slow coronary flow.

Fatih Koc1, Nihat Kalay, Hakan Kilci, Koksal Ceyhan, Atac Celik, Hasan Kadi, Bekir Calapkorur, Ahmet Celik, Orhan Onalan.   

Abstract

We investigated the relationship between renal function and coronary thrombolysis in myocardial infarction frame count (TFC) in patients with slow coronary flow (SCF). The patient group was composed of 34 patients with SCF. The control group was made up of 34 well-matched individuals who have normal SCF in their coronary arteries. The coronary flow rates of all subjects were documented by TFC. Glomerular filtration rate (GFR) and corrected GFR (cGFR) were calculated by creatinine clearance according to the Cockcroft-Gault formula. There is no difference in the gender or age of the groups. Blood urea nitrogen and creatinine were significantly higher in the SCF group compared the control group (blood urea nitrogen: 17 ± 6 mg/dL vs. 14 ± 4 mg/dL, p=0.04 and creatine: 0.9 ± 0.1mg/dL vs. 0.7 ± 0.1mg/dL, p=0.01). GFR and cGFR were significantly different between the groups (GFR: 92 ± 28 mL/min vs. 112 ± 27 mL/min, p=0.004 and cGFR: 77 ± 22 mL/min/1.73 m(2)vs. 96 ± 24 mL/min/1.73 m(2), p=0.007). There was a negative correlation between GFR/cGFR and TFC in all coronary arteries. This study shows that impaired renal function is associated with SCF. Patients with SCF have worse renal function compared with patients without SCF.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 21354518     DOI: 10.1016/j.kjms.2010.12.003

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  1 in total

1.  Transient no reflow following primary percutaneous coronary intervention.

Authors:  Hiroyuki Jinnouchi; Kenichi Sakakura; Hiroshi Wada; Kenshiro Arao; Norifumi Kubo; Yoshitaka Sugawara; Hiroshi Funayama; Shin-ichi Momomura; Junya Ako
Journal:  Heart Vessels       Date:  2013-06-27       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.